![]() |
市場調查報告書
商品編碼
1968551
跳蚤和蜱蟲防治產品市場-全球產業方法、市場佔有率、趨勢、機會和預測,按產品類型、寵物類型、方法、分銷管道、地區和競爭格局分類,2021-2031年Flea and Tick Product Market - Global Industry Method, Share, Trends, Opportunity and Forecast, By Product Type, By Pet Type, By Method, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球跳蚤和蜱蟲防治產品市場預計將從 2025 年的 87.3 億美元成長到 2031 年的 149.2 億美元,複合年成長率達到 9.34%。
該市場涵蓋多種化學和藥物製劑,包括口服藥物、藥用項圈和外用藥物,旨在控制或清除伴侶動物的體外寄生蟲。推動這一市場成長的主要因素是「寵物人性化」趨勢的日益盛行,即寵物被視為家庭成員,需要定期進行醫療保健以預防寄生蟲疾病。寵物擁有率的不斷提高進一步支撐了這一需求,擴大了獸用級防護產品的基本客群。根據美國寵物用品協會 (APPA) 預測,到 2025 年,美國寵物相關產業的總支出預計將達到 1,520 億美元,這主要得益於擁有至少一隻寵物的家庭數量創歷史新高,達到 9,400 萬戶。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 87.3億美元 |
| 市場規模:2031年 | 149.2億美元 |
| 複合年成長率:2026-2031年 | 9.34% |
| 成長最快的細分市場 | 貓 |
| 最大的市場 | 北美洲 |
儘管有這些正面因素,但由於家庭經濟壓力導致消費者對價格更加敏感,市場擴張仍面臨許多障礙。高通膨往往迫使寵物飼主轉而使用價格更低的非專利藥或推遲治療,從而導致高級產品的銷售下降。此外,對新化學品的嚴格監管進一步加劇了這種經濟負擔,導致新一代驅蟲藥的研發成本增加,並延緩了其商業性化上市。
氣候變遷正在擴大寄生蟲的季節性和地理分佈範圍,改變產業結構,並成為市場成長的重要外部因素。全球氣溫上升和降水模式改變正在延長體外寄生蟲的繁殖季節。蜱蟲和蚊子等媒介在以往難以生存的地區繁殖,因此需要全年採取防護措施。這種環境變化推動了需求的成長,因為為了降低疾病風險,預防性藥物的服用時間往往更長。根據伴侶動物寄生蟲委員會 (CAPC) 2024 年 4 月發布的報告《2024 年寵物寄生蟲預測》,監測數據證實了蜱傳病原體向南擴散的趨勢,報告顯示北卡羅來納州北部監測縣的萊姆病患病率高達 44%。
同時,新型給藥系統和產品配方的進步正在創造頻譜、便利的解決方案,從而提升市場價值。製造商正從傳統的滴劑配方轉向咀嚼片和複方療法,這些療法只需一次給藥即可同時清除體內寄生蟲、跳蚤和蜱蟲,從而提高患者依從性並支撐高價。這種向全面療效的轉變也體現在行業領導者的財務表現。例如,碩騰公司在2024年11月發布的2024年第三季財報中指出,其複方驅蟲藥Simparica Trio的銷售額達到2.68億美元,年增30%。同樣,默克公司報告稱,其Bravecto產品線的全球銷售額在2024年第三季達到2.66億美元,這體現了市場對成熟口服製劑的持續需求。
全球跳蚤和蜱蟲防治產品市場的成長正受到家庭經濟壓力的顯著阻礙。這導致消費者對價格更加敏感,購買習慣也隨之改變。高通膨限制了可支配收入,迫使寵物飼主重新評估獸醫護理支出,並將預防性驅蟲視為可有可無的支出,而非必需品。這些經濟限制導致消費者對推薦治療方案的依從性降低,並轉向價格較低的學名藥。因此,高階品牌產品的銷售下滑,整體營收成長停滯不前。
這種經濟謹慎的趨勢在整個獸醫行業普遍存在,而獸醫行業正是這些藥品的重要通路。根據澳洲動物藥品協會(Animal Medicines Australia)2025年的數據,約有18%的貓飼主和14%的狗飼主因經濟拮据而推遲了疫苗接種、健康檢查或治療。此類常規專業護理的中斷直接阻礙了跳蚤和蜱蟲防治產品的持續使用,降低了產品週轉率,並減緩了市場商業性發展勢頭。
消費者訂閱模式的興起正在從根本上改變全球跳蚤和蜱蟲防治產品市場的通路,其優先考慮的是持續的收入和便利性,而非傳統的獸醫處方購買。寵物飼主擴大選擇數位化自動續訂服務,以確保持續使用驅蟲產品,無需重複交易或前往實體店,從而繞過了傳統寵物診所。這種結構性變革不僅保障了大型零售商的現金流,也透過自動配送預防性治療方案直接解決了合規性問題。根據Chewy於2024年12月發布的2024年第三季財報,自動配送訂閱收入達23億美元,年增8.7%,占公司總銷售額的80%。
同時,人們對傳統合成化學品毒性的擔憂導致天然和植物配方產品的需求激增,推動了產品創新。飼主積極尋找使用植物來源和精油的「潔淨標示」害蟲防治產品,以降低敏感動物副作用的風險。這一領域正從利基市場發展成為快速成長的商業力量,促使製造商增加無毒解決方案的產量。根據 Wonderside 公司 2024 年 5 月宣布的總部搬遷計劃(由於兩位數成長),其植物來源害蟲防治產品的銷量在過去兩年成長了兩倍,因此需要將產能提高四倍以滿足不斷成長的消費者需求。
The Global Flea and Tick Product Market is projected to expand from USD 8.73 billion in 2025 to USD 14.92 billion by 2031, achieving a CAGR of 9.34%. This market comprises various chemical and pharmaceutical formulations, such as oral medications, medicated collars, and topical solutions, designed to control or eliminate external parasites on companion animals. A primary catalyst for this growth is the rising trend of pet humanization, where owners treat animals as family members deserving of regular preventive healthcare to avoid parasitic diseases. This demand is further supported by increasing pet adoption rates, which widen the customer base for veterinary-grade protection. According to the American Pet Products Association, total industry spending in the United States hit 152 billion dollars for the previous year in 2025, fueled by a record 94 million households owning at least one pet.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 8.73 Billion |
| Market Size 2031 | USD 14.92 Billion |
| CAGR 2026-2031 | 9.34% |
| Fastest Growing Segment | Cat |
| Largest Market | North America |
Despite these positive drivers, market expansion faces significant hurdles due to economic pressures on household budgets, which increase consumer price sensitivity. High inflation often forces pet owners to opt for lower-cost generic alternatives or delay treatments, thereby lowering sales volumes for premium products. This financial strain is exacerbated by a strict regulatory landscape for new chemical entities, which raises development costs and slows the commercial introduction of next-generation parasiticides.
Market Driver
Climate variations are reshaping the industry by expanding the seasonality and geographical range of parasites, serving as a critical external force for market growth. Rising global temperatures and altering precipitation patterns have prolonged the active breeding periods of ectoparasites, allowing vectors such as ticks and mosquitoes to flourish in areas that were previously inhospitable and necessitating year-round protection strategies. This shift in the environment drives volume growth as pet owners must administer preventatives for extended periods to lower disease risks. According to the Companion Animal Parasite Council's April 2024 '2024 Pet Parasite Forecast', surveillance data confirmed the southward spread of tick-borne pathogens, noting a Lyme disease prevalence rate of 44% in a sentinel county in northern North Carolina.
Concurrently, advancements in novel delivery systems and product formulations are boosting market value through the creation of broad-spectrum, convenient solutions. Manufacturers are moving away from traditional topical spot-ons toward palatable oral chews and combination therapies that address internal parasites, fleas, and ticks in a single dose, which improves compliance and supports premium pricing. This move toward comprehensive efficacy is reflected in the financial results of industry leaders. For instance, Zoetis reported in its November 2024 'Third Quarter 2024 Financial Results' that sales of the combination parasiticide Simparica Trio hit 268 million dollars, marking an operational growth of 30%. Similarly, demonstrating the ongoing demand for established oral innovations, Merck reported that third-quarter global sales for the Bravecto line totaled 266 million dollars in 2024.
Market Challenge
The growth of the Global Flea and Tick Product Market is significantly hindered by economic pressures on household budgets, which heighten consumer price sensitivity and modify purchasing habits. As high inflation restricts discretionary income, pet owners are forced to reevaluate veterinary spending, frequently viewing preventative parasiticides as optional rather than essential. These financial constraints result in lower adherence to recommended treatment schedules and prompt a transition toward less expensive generic alternatives. As a result, the market faces a reduction in the sales volume of premium branded formulations and a stagnation in overall revenue growth.
This pattern of financial caution is measurable across the broader veterinary sector, a vital distribution channel for these pharmaceutical products. Data from Animal Medicines Australia in 2025 indicates that approximately 18 percent of cat owners and 14 percent of dog owners deferred vaccinations, check-ups, or treatments because of financial limitations. Such interruptions in routine professional care directly break the consistent application of flea and tick solutions, thereby decreasing the frequency of product turnover and slowing the market's commercial momentum.
Market Trends
The rise of Direct-to-Consumer subscription models is fundamentally transforming distribution channels within the Global Flea and Tick Product Market by emphasizing recurring revenue and convenience over traditional veterinary purchasing. Pet owners are increasingly skipping clinical retailers in favor of digital auto-replenishment services that guarantee consistent parasiticide adherence without the need for repetitive transactions or physical store visits. This structural evolution not only secures cash flow for major retailers but also directly mitigates compliance gaps by automating the delivery of preventative treatments. According to Chewy's 'Third Quarter 2024 Financial Results' released in December 2024, Autoship subscription revenue increased by 8.7 percent year-over-year to 2.3 billion dollars, now comprising 80 percent of the company's total net sales.
At the same time, a surge in demand for natural and plant-based formulations is reshaping product innovation, as toxicity concerns regarding conventional synthetic chemicals push consumers toward botanical alternatives. Owners are actively searching for "clean label" parasiticides that use plant-derived compounds and essential oils to reduce the risk of adverse reactions in sensitive animals. This segment has evolved from a niche category into a rapidly expanding commercial force, driving manufacturers to scale up production for non-toxic solutions. According to Wondercide's May 2024 announcement regarding their headquarters relocation due to double-digit growth, sales for their plant-based pest control products have tripled over the past two years, requiring a quadrupling of manufacturing capacity to satisfy this growing consumer demand.
Report Scope
In this report, the Global Flea and Tick Product Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Flea and Tick Product Market.
Global Flea and Tick Product Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: